Space investing: Europe’s growing space sector
Investors Business Daily | June 2, 2023
Raghav Mittal, Assistant Director, Acuity Knowledge Partners’ recently spoke to Investors.com, a platform for individual and professional investors. He speaks about the growing trend of large pharmaceutical companies acquiring smaller biotech companies with promising oncology or immunology programs.
‘Acquisitions of biotech companies working on oncology or immunology treatments could be worth $5 billion to $25 billion a pop’, he explains.
Latest News
Bloomberg
“Campaign to Kill Off Libor Is Boosted by Landmark Bond Sale”
Read More
Reuters
“U.S. loan funds see fifth consecutive weekly inflow: Lipper”
Read More
Private Equity Wire
Expecting More: The evolving demand for ESG and impact investing | Private Equity Wire
Read More
People Management
Why businesses must seize the opportunity for cross-border recruitment
business growth, cross border clients, digital world
Read More
Institutional Real Estate inc
Dark times: Lower-grade office stock is weighing down portfolios across Europe — but offloading or improving assets is no easy task
arbitrage, Commercial Real Estate, conversion to office
Read More
Global Finance